The prevention of cutaneous malignant melanoma: high-risk groups, chemoprevention, education, and screening.
Melanoma is a disease that need not be deadly. Advances in our understanding of the etiology and biology of melanoma over the past 20 years have brought us to the brink of a new era in which the twin goals of primary and secondary prevention may be within our grasp. There is ample reason to be optimistic that this can and will be accomplished.
Greene
M H
MH
Department of Medicine, Mayo Clinic Scottsdale, AZ 85259.
D000818:Animals; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D004416:Dysplastic Nevus Syndrome / Q000188:drug therapy; D000518:Eflornithine / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008403:Mass Screening; D008545:Melanoma / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control*; D008546:Melanoma, Experimental / Q000517:prevention & control; D010353:Patient Education as Topic; D012176:Retinoids / Q000627:therapeutic use; D012307:Risk Factors; D012878:Skin Neoplasms / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control*; D013473:Sunscreening Agents / Q000627:therapeutic use
D016588:Anticarcinogenic Agents; D012176:Retinoids; D013473:Sunscreening Agents; D005472:Fluorouracil; D000518:Eflornithine